Department of Chemistry, The University of Texas at Austin, Austin, Texas, USA; email:
Department of Surgery, Baylor College of Medicine, Houston, Texas, USA; email:
Annu Rev Anal Chem (Palo Alto Calif). 2023 Jun 14;16(1):1-25. doi: 10.1146/annurev-anchem-061020-015544. Epub 2023 Mar 21.
Offering superb speed, chemical specificity, and analytical sensitivity, direct mass spectrometry (MS) technologies are highly amenable for the molecular analysis of complex tissues to aid in disease characterization and help identify new diagnostic, prognostic, and predictive markers. By enabling detection of clinically actionable molecular profiles from tissues and cells, direct MS technologies have the potential to guide treatment decisions and transform sample analysis within clinical workflows. In this review, we highlight recent health-related developments and applications of direct MS technologies that exhibit tangible potential to accelerate clinical research and disease diagnosis, including oncological and neurodegenerative diseases and microbial infections. We focus primarily on applications that employ direct MS technologies for tissue analysis, including MS imaging technologies to map spatial distributions of molecules in situ as well as handheld devices for rapid in vivo and ex vivo tissue analysis.
直接质谱 (MS) 技术具有出色的速度、化学特异性和分析灵敏度,非常适合对复杂组织进行分子分析,以帮助进行疾病特征描述并帮助识别新的诊断、预后和预测标志物。通过能够从组织和细胞中检测到具有临床可操作性的分子谱,直接 MS 技术有可能指导治疗决策并改变临床工作流程中的样本分析。在这篇综述中,我们重点介绍了直接 MS 技术在与健康相关的最新发展和应用,这些技术具有加速临床研究和疾病诊断的实际潜力,包括肿瘤学和神经退行性疾病以及微生物感染。我们主要关注的是将直接 MS 技术用于组织分析的应用,包括用于原位映射分子空间分布的 MS 成像技术以及用于快速进行体内和体外组织分析的手持式设备。